Interacting with tumor cells, MSCs upregulate RANKL and reduce its soluble receptor OPG, thus prompting osteoclastogenesis through the activation of RANKL-RANK signaling in osteoclasts [159]. The gene discussed is TNFSF11; the disease is neoplasm.